ArticleThe Journal of clinical investigation2024

METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2.

Weicheng Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.